z-logo
open-access-imgOpen Access
miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells
Author(s) -
Yingjie Li,
Wen Zhang,
Hui Xia,
Bao-Shi Zhang,
Ping Chen,
Yunlong Zhao,
Jie Li
Publication year - 2017
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2017-0398
Subject(s) - epithelial–mesenchymal transition , adenocarcinoma , cancer research , transition (genetics) , mesenchymal stem cell , lung , microrna , biology , medicine , microbiology and biotechnology , gene , cancer , genetics
Aim: Although, miR-218 has been implicated in epithelial-to-mesenchymal transition process, the detailed mechanisms of miR-218 involvement in epithelial-to-mesenchymal transition in human lung adenocarcinoma cell are still unclear. Materials & methods: miR-218 function assays and its target gene analysis were performed. Results: miR-218 suppresses human lung adenocarcinoma cell migration and invasion and inhibits its target gene, Ecop and Robo1 expression, which subsequently suppresses NF-κB activity and its downstream targets. Conclusion: miR-218 inhibits human lung adenocarcinoma cell migration and invasion via the suppression of Ecop and Robo1 expression, thus suggesting that miR-218 could serve as a potential therapeutic target.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom